The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic ...

The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid ...

Survival rates for people with cholangiocarcinoma, a silent but deadly form of cancer originating in the bile ducts, are dismal and a new approach is needed, argues a panel of leading experts ...

Dr. Shaun P. McKenzie discusses bile duct cancer challenges and why awareness and specialized care help patients get ...

The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also ...

Rachna Shroff, MD, is the associate director of clinical investigations at the U of A Cancer Center and a professor and chief of the division of hematology and oncology at the College of Medicine – ...

The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic capabilities. Increasing adoption ...

Biliary tract cancers, including cholangiocarcinoma and gallbladder carcinoma, represent a heterogeneous group of malignancies with rising global incidence and persistent dismal prognoses. Research in ...

When do you have tests for bile duct cancer? Bile duct cancer is also called cholangiocarcinoma. It is a rare type of cancer that develops in the bile ducts. Most people are diagnosed with bile duct ...

The MHRA approved a first-in-class bispecific antibody for HER2-positive biliary tract cancer, offering a new line of therapy for patients who have progressed on standard care.

The Jeffrey Speller Foundation “4 Change” hosted its first ever Celebrity Drink Night on Friday to raise funds for bile duct ...